Short-term adverse effects of 5-aminosalicylic acid agents in the treatment of ulcerative colitis-Reference-Cited by-同舟云学术

Short-term adverse effects of 5-aminosalicylic acid agents in the treatment of ulcerative colitis

Published:2004-01 Issue:2 Volume:19 Page:179-189
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:

Author:

Loftus E. V.,Kane S. V.,Bjorkman D.

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.0269-2813.2004.01827.x/fullpdf

Reference56 articles.

1. Salazyopyrin, a new sulfanilamide preparation: A. Therapeutic results in rheumatic polyarthritis. B. Therapeutic results in ulcerative colitis. C. Toxic manifestations in treatment with sulfanilamide preparation;Svartz;Acta Med Scand,1942

2. An experiment to determine the active therapeutic moiety of sulphasalazine;Azad Khan;Lancet,1977

3. Users' guides to the medical literature. IV. How to use an article about harm. Evidence-Based Medicine Working Group;Levine;J Am Med Assoc,1994

4. Sulfasalazine revisited: a meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis;Sutherland;Ann Intern Med,1993

5. Alternatives to sulfasalazine - a meta-analysis of 5-ASA in the treatment of ulcerative colitis;Sutherland;Inflamm Bowel Dis,1997

Cited by 158 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Working Together: Advances in Probiotics Combined with Mesalazine in the Treatment of Ulcerative Colitis;Advances in Clinical Medicine;2024

2. Risiken und Nebenwirkungen der medikamentösen Therapie;Pflege bei chronisch-entzündlichen Darmerkrankungen;2023

3. Perspectives of colon-specific drug delivery in the management of morning symptoms of rheumatoid arthritis;Inflammopharmacology;2022-12-21

4. Perimyokarditis als Komplikation einer medikamentösen Mehrfachtherapie bei Colitis ulcerosa;DMW - Deutsche Medizinische Wochenschrift;2022-08

5. Pharmacokinetic and gut microbiota analyses revealed the effect of Lactobacillus acidophilus on the metabolism of Olsalazine in ulcerative colitis rats;European Journal of Pharmaceutical Sciences;2022-08